BioNTech建议CureVac股东在2025年12月2日星期二东部时间下午6点前递交其股票

投资观察
Nov 26

11月26日 - BioNTech SE宣布,CureVac于2025年11月25日举行的特别股东大会上批准了与其公开收购(“要约”)有关的事项,涉及CureVac N.V.(NASDAQ:CVAC,简称“CureVac”)的所有已发行股票。CureVac的股东被建议在2025年12月2日星期二东部时间下午6点之前递交他们的股票。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10